SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-046320
Filing Date
2021-11-30
Accepted
2021-11-30 17:26:17
Documents
1
Period of Report
2021-11-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 16159
  Complete submission text file 0000899243-21-046320.txt   17664
Mailing Address C/O MEDICXI COURS DE RIVE 10 GENEVA V8 CH-1204
Business Address
De Rubertis Francesco (Reporting) CIK: 0001601521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40445 | Film No.: 211460470

Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Issuer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations